NeuroPharmac 2020

Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19) https://doi.org/10.37881/1.511 2020, Volume 5, Issue 1 (January-April) [Download Full PDF] Urgent health challenges for the next decade 2030: World Health Organization https://doi.org/10.37881/1.512 2020, Volume 5, Issue 1 (January-April) [Download Full PDF] Lamotrigine and Phenytoin indicated for epilepsy recalled by the manufacturer in America https://doi.org/10.37881/1.513 2020, Volume 5, Issue 1 (January-April) [Download Full PDF]

NeuroPharmac 2019

Autism Spectrum Disorder: Medications overview https://doi.org/10.37881/1.411 2019, Volume 4, Issue 1 (January-April) [Download Full PDF] FDA-approves the first therapy in 2018 for the seizures associated with Dravet syndrome https://doi.org/10.37881/1.412 2019, Volume 4, Issue 1 (January-April) [Download Full PDF] Cannabidiol: FDA approved new drug for the Lennox-Gastaut syndrome and Dravet Syndrome: Pharmacotherapeutics review https://doi.org/10.37881/1.413 2019, Volume 4, Issue 1 (January-April) [Download Full PDF] Caplacizumab: First FDA-approved therapy in 2019 for the treatment of adult patients with acquired thrombotic thrombocytopenic purpura https://doi.org/10.37881/1.414 2019, Volume 4, Issue 1 (January-April) [Download Full PDF] Stiripentol:…

NeuroPharmac 2016

Multiple Sclerosis: Promising New Treatment – A Clinical Review https://doi.org/10.37881/1.110 2016, Volume 1, Issue 1 (Sept-Dec) [Download Full PDF] Curcuma caesia rhizomes: evaluation of antiasthmatic effect by using clonidine induced mast cell degranulation htpps://doi.org/10.37881/1.112 2016, Volume 1, Issue 1 (Sept-Dec) [Download Full PDF] Evaluation of Antiasthmatic effect of Curcuma zedoaria rhizomes by using milk induced leukocytosis in mice https://doi.org/10.37881/1.113 2016, Volume 1, Issue 1 (Sept-Dec) [Download Full PDF] Peganum harmala seeds: evaluation of antiasthmatic effect by using clonidine induced mast cell degranulation https://doi.org/10.37881/1.114 2016, Volume 1, Issue 1 (Sept-Dec) [Download…

NeuroPharmac 2017

Cerebral palsy: Basic Approach and Oral Medications https://doi.org/10.37881/1.211 2017, Volume 2, Issue 1 (Jan-April) [Download Full PDF] Phytochemical Investigations of Indigenous herb: Curcuma caesia rhizomes https://doi.org/10.37881/1.221 2017, Volume 2, Issue 2 (May-August) [Download Full PDF] Essential Tremor: β blockers a first-line therapy https://doi.org/10.37881/1.231 2017, Volume 2, Issue 3 (Sept-Dec) [Download Full PDF]

NeuroPharmac 2018

Alzheimer’s Disease: Pharmacotherapy of noncognitive symptoms https://doi.org/10.37881/1.311 2018, Volume 3, Issue 1 (Jan-April) [Download Full PDF] Comparative study between open & closed dressing in healing of burn wound https://doi.org/10.37881/1.312 2018, Volume 3, Issue 1 (Jan-April) [Download Full PDF] Alzheimer’s Disease: Pharmacotherapy of subjective cognitive decline https://doi.org/10.37881/1.321 2018, Volume 3, Issue 2 (May-August) [Download Full PDF] Gold Standard of Symptomatic treatment in Parkinson disease: Carbidopa/Levodopa https://doi.org/10.37881/1.331 2018, Volume 3, Issue 3 (Sept-Dec) [Download Full PDF] Possible management of non-motor symptoms of Parkinson’s Disease https://doi.org/10.37881/1.332 2018, Volume 3, Issue 3 (Sept-Dec) [Download…